Life science company focused on solving Duchenne muscular dystrophy

Biotechnology

Solid Biosciences

Solid Biosciences' headquarters in Cambridge, MA, United States

Bo Cumbo

Gabriel Brooks

Kevin T.

Kimberly Audet Cornwell

Shuli Kulak

Melanie Von Schimmelmann

Kevin Tan

Paul Herzich

Jessie Hanrahan

Ty Howton

Matt Arnold

Adam Stone

Adam Koppel

Rajeev Shah

Ian F. Smith

Clare Kahn

Martin Freed

Sukumar Nagendran

The Research and Development Scientists at Solid Biosciences are dedicated to advancing innovative therapies for Duchenne muscular dystrophy (DMD). This team conducts cutting-edge research, develops and optimizes experimental protocols, and collaborates on preclinical studies to enhance understanding of DMD pathophysiology. Their efforts aim to translate scientific discoveries into effective treatments, ensuring the progression from lab discoveries to clinical applications.

Research and Development Scientists

The Leadership Team at Solid Biosciences is responsible for steering the company's strategic vision and operational execution in the pursuit of innovative treatments for Duchenne muscular dystrophy. This team comprises experts in various fields, including research, regulatory affairs, finance, and human resources, collaboratively guiding the research and development process, managing resources, and ensuring compliance with industry standards to drive the company’s mission forward.

Leadership Team

The Business Development and Strategy team at Solid Biosciences is dedicated to identifying and pursuing strategic partnerships, collaborations, and investment opportunities that align with the company's mission to address Duchenne muscular dystrophy. The team works closely with various departments to assess market trends, develop business strategies, and drive growth initiatives, all while ensuring legal and compliance standards are met. Their collective expertise enables Solid Biosciences to effectively navigate the competitive landscape of the life sciences industry.

Business Development and Strategy

The Finance and Accounting team at Solid Biosciences plays a critical role in managing the company's financial health and analytical processes. They oversee budgeting, forecasting, and strategic financial planning to ensure effective resource allocation, while also handling regulatory compliance, financial reporting, and accounting operations to support the company's mission of advancing treatments for Duchenne muscular dystrophy.

Finance and Accounting

The Operations & Engineering team at Solid Biosciences is responsible for optimizing internal processes and ensuring efficient lab operations to support the development of therapies for Duchenne muscular dystrophy. This team manages human resources and administrative functions while also focusing on the engineering and operational aspects of research and production, enabling seamless collaboration between departments to drive innovation and streamline workflows.

Operations & Engineering

The Clinical Development Team at Solid Biosciences is responsible for designing and overseeing clinical trials aimed at evaluating the safety and efficacy of treatments for Duchenne muscular dystrophy. This team collaborates closely with regulatory bodies, manages study protocols, and ensures compliance with clinical guidelines, ultimately driving innovative therapies from the lab into patient care.

Solid Biosciences

Org chart

Board & advisors

Teams

Research and Development Scientists

Leadership Team

Business Development and Strategy

Finance and Accounting

Operations & Engineering

Clinical Development Team

Offices

Solid Biosciences

Org chart

Board & advisors

Teams

Research and Development Scientists

Leadership Team

Business Development and Strategy

Finance and Accounting

Operations & Engineering

Clinical Development Team

Offices

Related companies